ArticlemAbs2026

JMB2403, a potential best-in-class PD-1-dependent IL2Rβγ-activating tri-specific antibody for safe and potent immunotherapy.

Chunyin Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.